Viemed Healthcare (VMD) Peer Comparison

$8.79

$-0.29 (-3.19%)

As on 08-Sep-2026 16:00EDT

Market cap

$346 Mln

Revenue (TTM)

$302 Mln

P/E Ratio

25.2

P/B Ratio

2.4

Div. Yield

0 %

Edit

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Market cap ($ Mln)	346	6,413	252
Revenue ($ Mln)	302	5,319	19
Net Profit ($ Mln)	14.50	-171.00	-32.65
Net Margin (%)	4.81	-3.21	-171.72
RoE (%)	9.78	-2.79	-46.38
Price to Earnings	25.22	--	--
Price-To-Book	2.39	1.00	5.00

Cashflow
Ratios

Cashflow ($ Mln)

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Cash From Operating Activities	51.92	283.00	-38.88
Cash Flow from Investing Activities	-50.17	-455.00	-0.25
Cash from Financing Activities	-5.79	225.00	41.86
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
ROCE (%)	10.10	-3.10	-53.15
ROE (%)	9.78	-2.79	-46.38
ROA (%)	6.12	-1.09	-51.46
EBIT Margin (%)	7.75	6.22	-177.13
Net Margin (%)	4.81	-3.21	-171.72
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Revenue Growth (%)	25.21	8.75	62.18
EBIT Growth (%)	31.75	967.74	22.64
Net Profit Growth (%)	3.73	37.36	20.60
EPS Growth (%)	5.67	37.71	32.81
Book Value Growth (%)	2.97	-1.94	4.83

Valuation Ratios

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Price / Earnings	19.98	-16.81	-5.58
Price / Book Value	2.11	0.94	2.66
Dividend Yield (%)	--	--	--
EV/EBITDA	5.83	20.64	-4.02
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Debt to Equity	0.04	0.80	0.00
Short term debt to equity ratio	0.01	0.01	0.09
Current Ratio	1.13	1.55	6.45
Quick Ratio	1.02	1.02	5.31
Interest Coverage	15.88	0.84	--

Operating Efficiency Ratios

	Viemed Healthcare (VMD)	Bausch + Lomb Corp (BLCO)	Profound Medical (PROF)
Debtors to sales (%)	10.69	21.81	50.57
Asset Turnover	1.27	0.34	0.30
Receivable days	34.12	80.45	188.50
Inventory Days	14.90	159.20	651.71
Payable days	34.46	61.48	131.90
Cash Conversion Cycle	14.56	178.17	708.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly